Ultrastructural study of cerebellar dentate nucleus astrocytes in chronic experimental model with valproate
Journal Title: Folia Neuropathologica - Year 2005, Vol 43, Issue 3
Abstract
The current study focuses on the morphogenesis of changes in the cerebellum dentate nucleus in the course of experimental valproate encephalopathy. Valproate – a broad spectrum antiepileptic and antipsychotic drug – chronically used in rats, intragastrically, once daily at a dose of 200 mg/kg b. w. for 1, 3, 6, 9 and 12 months, induced pronounced ultrastructural changes in the population of glial cells and nerve cells of the dentate nucleus of the cerebellum in the last two phases of the experiment. Astrocytic and neuronal lesions coexisted with a considerable damage to the elements of the blood-brain barrier of the cerebellar structure examined. The changes affected mainly the population of protoplasmic astrocytes lying loosely in a neuropile as well as astrocytes adhering to damaged large multipolar neurons. Focal proliferation of astrocytes was observed. Abnormal astrocytes showed marked swelling expressed by significantly decreased electron density of the cytoplasm that contained almost empty vacuolar structures and by a considerably reduced number of intracellular organelles. It was accompanied by dilation of endoplasmic reticular channels, loss of fibrillopoietic capacity of the cell and features of autophagocytosis. It should be assumed that the essential cause of protoplasmic astroglial damage of the cerebellar dentate nucleus could be associated, apart from the direct effect of valproate and/or its metabolites on these cells, with changes in structural elements of the blood-brain barrier of this CNS region.
Authors and Affiliations
Maria Sobaniec-Łotowska, Joanna Łotowska
Keywords
Related Articles
- EP ID EP91113
- DOI -
- Views 106
- Downloads 0
Microglial cells in neurodegenerative disorders
Microglia are resident immune cells of the CNS. They are involved in the pathogenesis of diverse neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, prion diseases as well as multiple sclerosis,...
Short-term treatment with rivastigmine and plasma levels of Ab peptides in Alzheimer’s disease
Deregulation of APP metabolism is considered to be a key pathogenic event in Alzheimer’s disease. Data from cell cultures indicate that the secretion of Ab1-42 might be inhibited by cholinesterase inhibitors, possibly...
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence
Prion diseases or transmissible spongiform encephalopathies (TSEs) are rare neurodegenerative disorders that can be acquired either by direct transmission, inherited through dominant mutations in the prion protein gene o...
Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion
Variant Creutzfeldt-Jakob disease (vCJD) was first identified in 1996 in the UK, and results from human exposure to the bovine spongiform encephalopathy (BSE) agent. vCJD has subsequently been identified in 10 additional...
Teratoma or enterogenous cyst? The histopathological and clinical dilemma in co-existing occult neural tube dysraphism
Background: Better understanding of embryology, histopathology and genetics of dysraphic conditions have lead to an expansion of this concept to entities with a similar microscopic appearance (e.g. enterogenous cysts, co...